Home - sovren.media

  • Login
Pennsylvania University Study Finds MRNA Vaccines Gives 5-10% Of Recipients Severe Adverse Reactions Up Next Pennsylvania University Study Finds MRNA Vaccines Gives 5-10% Of Recipients Severe Adverse Reactions

CDC’s Flimsy Study, Digital DL/Vaccine Card & Italian Dept Of Health Revises COVID Deaths To 3783

1,200 views
11/02/2021
  • 32
  • 4
  • Support
    • Share on Sovren
    • Share on Telegram
    • Share on Facebook
    • Share on Twitter
    • Share on Reddit
    • Copy Link
    • Copy Embed Code
TLAVagabond TLAVagabond Verified User 5K followers
Follow
https://www.thelastamericanvagabond.com/cdcs-flimsy-study-digital-dl-vaccine-card-italian-dept-of-health-revises-covid-deaths-to-3783

You must be logged in to post wall comments. Please Login or Signup (free).

Share
(Click in textarea to copy code) Code copied to clipboard.

Related

Pennsylvania University Study Finds MRNA Vaccines Gives 5-10% Of Recipients Severe Adverse Reactions
Pennsylvania University Study Finds MRNA Vaccines Gives 5-10% Of Recipients Severe Adverse Reactions
TLAVagabond The Last American Vagabond Verified User 15.1K views 05/12/2021
WEF Admits COVID Was Around In Mid-2019 & It's Admitted The Vaccine Will NOT Return Us To Normal
WEF Admits COVID Was Around In Mid-2019 & It's Admitted The Vaccine Will NOT Return Us To Normal
TLAVagabond The Last American Vagabond Verified User 9.9K views 11/18/2020
Pfizer Altered Its Formulation For Kids 5-11
Pfizer Altered Its Formulation For Kids 5-11
TLAVagabond The Last American Vagabond Verified User 4.7K views 10/30/2021

Popular Creators

BenSwann Ben Swann Verified User 58K followers Follow
TLAVagabond TLAVagabond Verified User 5K followers Follow
Bringourtroopshome Bring Our Troops Home Verified User 1K followers Follow
AlexJones Alex Jones Verified User 5K followers Follow
JasonBassler Jason Bassler Verified User 254 followers Follow
  • Creators
  • Become a Creator
  • Resources
  • Press
  • Sponsor
  • Blog
  • Support
  • FAQ
  • Sovren Tokens
  • Token FAQ
  • Contact Us
  • About Us
  • Investors
Home - ise.media
©2022 Isegoria, Inc. All rights reserved.
Terms Privacy

Delete Post

Are you sure you want to delete this comment?

Yes